Skip to main content

Year: 2019

Man Group PLC : Form 8.3 – Hansteen Holdings

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).(b)       ...

Continue reading

Noranda Income Fund Announces Special Cash Distribution of 2019 Taxable Income

TORONTO, Dec. 19, 2019 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX:NIF.UN) (the “Fund”) announced today that the Board of Trustees of Noranda Operating Trust (the “Board” or “Trustees”) has approved a special cash distribution of $0.03 per unit payable on January 27, 2020, to Priority and Ordinary Unitholders of record as at the close of business on December 31, 2019. This special cash distribution is based on the Fund’s 2019 unconsolidated taxable income calculated in accordance with the Fund’s Trust Indenture.All cash distributions to unitholders must also be approved by the Fund’s debtholders and they have provided their consent for this special distribution.This special cash distribution does not signal a return to regular recurring monthly distributions to unitholders. Please...

Continue reading

Le Fonds de revenu Noranda annonce la distribution au comptant spéciale du bénéfice imposable de 2019

TORONTO, 19 déc. 2019 (GLOBE NEWSWIRE) — Le Fonds de revenu Noranda (TSX:NIF.UN) (le « Fonds ») a annoncé aujourd’hui que le conseil des fiduciaires de la Fiducie d’exploitation Noranda (le « conseil » ou les « fiduciaires ») a approuvé une distribution au comptant spéciale de 0,03 $ par part, payable le 27 janvier 2020 aux porteurs de parts ordinaires et prioritaires inscrits à la fermeture des bureaux le 31 décembre 2019. Cette distribution au comptant spéciale est fondée sur le bénéfice imposable non consolidé de 2019 du Fonds, calculé conformément à l’acte de fiducie du Fonds.Toutes les distributions au comptant aux porteurs de parts doivent...

Continue reading

Premier Health Announces Definitive Agreement to Acquire Livecare

Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active health practitioner accounts, some of which are multi-user sitesVANCOUVER, British Columbia, Dec. 19, 2019 (GLOBE NEWSWIRE) — Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” or “Premier Health”), a company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce that, further to its previous news release, it has entered into an amalgamation agreement to acquire all of the outstanding securities of Livecare Health Canada Inc. (“Livecare”).Livecare is a Canadian Telehealth company founded and operated by physicians...

Continue reading

Borregaard ASA: Pulpwood prices for 1st half 2020

Negotiations with most suppliers of spruce pulpwood and woodchips to the biorefinery in Sarpsborg are finished. Borregaard’s wood costs in the first half of 2020 will be NOK 25 – 30 million lower than in the first half of 2019, thus continuing the trend of lower prices observed also in the second half of 2019.Sarpsborg, 19 December 2019This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Continue reading

Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock

NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (Nasdaq: AXSM) (“Axsome” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced the pricing of an underwritten public offering of 2,000,000 shares of its common stock at a public offering price of $87.00 per share. The proceeds from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Axsome, are expected to be $174.0 million. In addition, Axsome has granted the underwriters a 30-day option to purchase up to 300,000 additional shares of common stock at the public offering price, less the underwriting discounts and commissions. The offering is expected...

Continue reading

Myriad Genetics’ Board Member, S. Louise Phanstiel, Recognized by WomenInc. Magazine in 2019 List of Most Influential Corporate Directors

SALT LAKE CITY, Dec. 19, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and precision medicine, announced that board member S. Louise Phanstiel has been named to WomenInc. Magazine’s 2019 Most Influential Corporate Board Directors list.  The list includes female directors serving on the boards of publicly traded companies and is the most comprehensive directory of women executives, influencers and achievers who contribute to leadership on corporate boards.“We congratulate Louise for this well-deserved acknowledgment of her leadership and many contributions to our success,” said Mark C. Capone, president and CEO of Myriad Genetics.  “At Myriad, we believe an inclusive work environment is one of the reasons we have been so successful through...

Continue reading

FIXING OF COUPON RATES – Nykredit Realkredit A/S

To Nasdaq Copenhagen19 December 2019FIXING OF COUPON RATES                                                                           Fixing of coupon rates effective from 1 January 2020Effective from 1 January 2020, the coupon rates of floating-rate bonds issued by Nykredit Realkredit A/S will be adjusted.Bonds with semi-annual interest rate fixingThe new coupon rates will apply from 1 January 2020 to 30 June 2020:Uncapped bondsDK0009508319, (32G), maturity in 2022,...

Continue reading

FASTSÆTTELSE AF KUPONRENTER  – Nykredit Realkredit A/S

Til Nasdaq Copenhagen19. december 2019FASTSÆTTELSE AF KUPONRENTER                                                               Fastsættelse af kuponrenter gældende fra den 1. januar 2020Med virkning fra den 1. januar 2020 ændres kuponrenten på variabelt forrentede obligationer udstedt af Nykredit Realkredit A/S.Obligationer med halvårlig rentefastsættelseDe nye kuponrenter er gældende fra den 1. januar 2020 til den 30. juni 2020:Obligationer uden renteloftDK0009508319, (32G), udløb...

Continue reading

Apergy to Combine with Ecolab’s Upstream Energy Business in a Tax-Free Transaction, Creating a Global Leader in Production-Optimization Solutions

Global leader for life of field production optimization solutions, including artificial lift equipment, chemical solutions, and digital technologies, offering customers increased productivity over the well lifecycle, with approximately 80% of revenue from production-related product linesCombined business expected to generate pro forma revenue of approximately $3.5 billion and adjusted EBITDA of approximately $615 million (before synergies) in 2019 with strong recurring revenue, cash flow, and through-cycle performanceExpected annual run-rate cost synergies of $75 million within 24 months of closing, plus incremental sales growth opportunities, benefiting both sets of shareholdersFinancially compelling transaction with strong benefits for Apergy and Ecolab shareholders, creating a combined company enterprise value of approximately $7.4 billion,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.